Our clinicians are very active members of the research community, actively participating in clinical trials with our patients to improve and increase the treatment options that are available for mesothelioma. As active researchers, they are also prolific authors. Many of their publications are freely available online.
If you would like to read more about these and other publications you have several options:
- To read the research produced by our director and associate professors, follow these links to view a complete list of their publications as curated in by the National Center for Biotechnology Information (NCBI). Once you have selected an article you are interested in reading (by clicking the title), free access articles will have a link on the upper right side of the webpage that you may follow to reach the article.**Links that have the words “free” or “full text” in the icon will be fully accessible to you.
- You may also conduct your own search on the NCBI site. First, select one of our physicians whose work you would like to read. Next, navigate to Pubmed and enter the physician’s name into the top search box. From there, you may navigate to any article that interests you following the same instructions as in option 1) above.
- We have made certain open-access articles available through the links below. You may select one by clicking the hyperlinked title. This link will take you to the article’s entry in the NCBI Pubmed database, where you can follow the links on the upper right side (similar to above) to go to the article.
Review Articles, Surgical Techniques and Expert Opinions
Management of Complications After Pneumonectomy. Groth SS, Burt BM, Sugarbaker DJ.
Thorac Surg Clin. 2015 Aug;25(3):335-48. doi: 10.1016/j.thorsurg.2015.04.006. Epub 2015 Jun 12. Review. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Pass H, Weder W, Sugarbaker DJ; participants in 2012 International Mesothelioma Interest Group Congress.
J Thorac Cardiovasc Surg. 2013 Apr;145(4):909-10. doi: 10.1016/j.jtcvs.2013.01.039. Epub 2013 Feb 14. No abstract available. Surgery for malignant pleural mesothelioma. Sugarbaker , Wolf AS.
Expert Rev Respir Med. 2010 Jun;4(3):363-72. doi: 10.1586/ers.10.35. Review. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Wolf AS, Daniel J, Sugarbaker DJ.
Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):132-48. doi: 10.1053/j.semtcvs.2009.07.007. Review. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. Sugarbaker DJ.
J Thorac Oncol. 2006 Feb;1(2):175-6. Review. No abstract available.
Clinical Research and Outcomes
Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. Baldini EH, Richards WG, Gill RR, Goodman BM, Winfrey OK, Eisen HM, Mak RH, Chen AB, Kozono DE, Bueno R, Sugarbaker DJ.
J Thorac Cardiovasc Surg. 2015 May;149(5):1374-81. doi: 10.1016/j.jtcvs.2014.10.128. Epub 2015 Feb 7. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Sugarbaker DJ, Richards WG, Bueno R.
Ann Surg. 2014 Oct;260(4):577-80; discussion 580-2. doi: 10.1097/SLA.0000000000000903. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ.
J Clin Oncol. 2013 Dec 20;31(36):4544-9. doi: 10.1200/JCO.2013.49.9616. Epub 2013 Nov 18. Clinical indications and results after chest wall resection for recurrent mesothelioma. Burt BM, Ali SO, DaSilva MC, Yeap BY, Richards WG, Baldini EH, Sugarbaker DJ.
J Thorac Cardiovasc Surg. 2013 Dec;146(6):1373-9; discussion 1379-80. doi: 10.1016/j.jtcvs.2013.07.012. Epub 2013 Oct 8. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG.
J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-63. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT, Bueno R, Richards WG.
Eur J Cardiothorac Surg. 2011 Aug;40(2):298-303. doi: 10.1016/j.ejcts.2010.12.024. Epub 2011 Feb 9. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Richards WG, Godleski JJ, Yeap BY, Corson JM, Chirieac LR, Zellos L, Mujoomdar A, Jaklitsch MT, Bueno R, Sugarbaker DJ.
Cancer. 2010 Mar 15;116(6):1510-7. doi: 10.1002/cncr.24886. Erratum in: Cancer. 2010 May Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, Yeap BY, Mujoomdar AA, Ducko CT, Bueno R, Sugarbaker DJ.
J Thorac Cardiovasc Surg. 2009 Aug;138(2):405-11. doi: 10.1016/j.jtcvs.2009.02.046. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. Zellos L, Richards WG, Capalbo L, Jaklitsch MT, Chirieac LR, Johnson BE, Bueno R, Sugarbaker DJ.
J Thorac Cardiovasc Surg. 2009 Feb;137(2):453-8. doi: 10.1016/j.jtcvs.2008.07.055. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR, Yeap BY, Dekkers RJ, Hartigan PM, Capalbo L, Sugarbaker DJ.
Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation. Burt BM, Bader A, Winter D, Rodig SJ, Bueno R, Sugarbaker DJ.
Clin Cancer Res. 2012 Mar 15;18(6):1568-77. doi: 10.1158/1078-0432.CCR-11-1808. Epub 2012 Jan 18. Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro. Gordon GJ, Bueno R, Sugarbaker DJ.
BMC Cancer. 2011 May 13;11:169. doi: 10.1186/1471-2407-11-169. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Burt BM, Rodig SJ, Tilleman TR, Elbardissi AW, Bueno R, Sugarbaker DJ.
Cancer. 2011 Nov 15;117(22):5234-44. doi: 10.1002/cncr.26143. Epub 2011 Apr 26. Characteristics of malignant pleural mesothelioma in women. Wolf AS, Richards WG, Tilleman TR, Chirieac L, Hurwitz S, Bueno R, Sugarbaker DJ.
Ann Thorac Surg. 2010 Sep;90(3):949-56; discussion 956. doi: 10.1016/j.athoracsur.2010.04.110. Transcriptome sequencing of malignant pleural mesothelioma tumors. Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R.
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3521-6. doi: 10.1073/pnas.0712399105. Epub 2008 Feb 26. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, Gnad F, Nguyen TT, Jaiswal BS, Chirieac LR, Sciaranghella D, Dao N, Gustafson CE, Munir KJ, Hackney JA, Chaudhuri A, Gupta R, Guillory J, Toy K, Ha C, Chen YJ, Stinson J, Chaudhuri S, Zhang N, Wu TD, Sugarbaker DJ, de Sauvage FJ, Richards WG, Seshagiri S. Nat Genet. 2016 Feb 29. doi: 10.1038/ng.3520.